© 2024 Boise State Public Radio
NPR in Idaho
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Boise State Public Radio would not be here without your support. Donate Today
Health
Idaho Matters Show logo
Idaho Matters

Idaho Matters Doctors Roundtable: October 11, 2023

By Gemma Gaudette
Published October 11, 2023 at 2:02 PM MDT
Novavax says its vaccine is 100% effective against the original strain of the coronavirus and had 93% efficacy against more worrisome variants.
Alastair Grant
/
AP
Novavax says its vaccine is 100% effective against the original strain of the coronavirus and had 93% efficacy against more worrisome variants.

Earlier this week vaccine maker Novavax said it had shipped millions of doses of its updated COVID-19 shots to distributors around the United States.

So what does that mean for folks looking to get this latest vaccine? Dr. David Pate, former CEO of St. Luke's Health System, joined Idaho Matters to help answer this question.

Tags
Idaho Matters COVID-19VaccinationDoctors Roundtable
Stay Connected
Gemma Gaudette
Hi! I’m Gemma Gaudette, the host of the award-winning show, Idaho Matters. During the day you’ll find me researching and writing about all the fascinating topics we tackle on our show. And of course, at noon, each weekday you’ll find me live behind the microphone as Idaho Matters airs.
See stories by Gemma Gaudette

You make stories like this possible.

The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.

Your donation today helps make our local reporting free for our entire community.

Donate